Causal relationship between COVID-19, vaccination, and 20 digestive diseases: a comprehensive two-sample Mendelian randomization study
- PMID: 40588731
- PMCID: PMC12207808
- DOI: 10.1186/s12985-025-02847-y
Causal relationship between COVID-19, vaccination, and 20 digestive diseases: a comprehensive two-sample Mendelian randomization study
Abstract
Background: Sequelae and complications have become a significant concern in the post-pandemic era of Coronavirus disease 2019 (COVID-19). However, it remains unclear whether there is a direct causal relationship between COVID-19 or vaccination and digestive diseases, as existing evidence is ambiguous and controversial. In this study, we investigated the associations between multiple COVID-19 infection phenotypes, vaccination, and 20 common digestive diseases, and explored their causal relationships through extensive Mendelian randomization (MR) analysis.
Methods: For individuals of European descent, we conducted an extensive two-sample Mendelian randomization (MR) analysis using genome-wide association study (GWAS) data. Six COVID-19 infection (six phenotypes) GWAS datasets and two vaccination (from the UK and Finland) GWAS datasets were used as exposure factors; 20 common digestive diseases were treated as outcome factors, with each disease having two or more GWAS datasets, mostly sourced from the UK Biobank and FinnGene platforms. Single nucleotide polymorphisms (SNPs) associated with the exposures were used as instrumental variables (IVs) to estimate the causal relationship between COVID-19, vaccination, and the 20 digestive diseases. Meta-analysis was conducted to assess the combined causal effect from multiple MR results.
Results: MR analysis revealed a causal relationship between COVID-19 and duodenal ulcer (P = 4.98E-03, OR = 1.00, 95% CI: 1.00-1.00). Additionally, COVID-19 hospitalization was associated with viral hepatitis (P = 4.94E-02, OR = 1.10, 95% CI: 1.00-1.21), cirrhosis (P = 1.72E-02, OR = 0.91, 95% CI: 0.85-0.98), and chronic pancreatitis (P = 1.48E-02, OR = 0.91, 95% CI: 0.84-0.98). Severe COVID-19 infection was linked to viral hepatitis (P = 3.57E-02, OR = 1.00, 95% CI: 1.00-1.00), cholelithiasis (P = 3.50E-02, OR = 1.00, 95% CI: 1.00-1.00), and Crohn's disease (P = 4.15E-02, OR = 0.96, 95% CI: 0.93-1.00). Meta-analysis further supported a causal link between COVID-19 and duodenal ulcer (P = 4.97E-03, OR = 1.00, 95% CI: 1.00-1.00), gastroesophageal reflux disease (P = 3.38E-02, OR = 1.04, 95% CI: 1.00-1.07), and chronic pancreatitis (P = 2.67E-03, OR = 0.92, 95% CI: 0.87-0.97). COVID-19 vaccination (Finland) was associated with an increased risk of gastroesophageal reflux disease (P = 3.38E-02, OR = 1.12, 95% CI: 1.01-1.24). After applying the Benjamini-Hochberg correction, no significant differences were observed in the meta-analysis results.
Conclusions: This extensive MR study found no strong causal relationship between COVID-19 infection, vaccination, and 20 common digestive diseases based on genetic data. These results help clarify the longstanding uncertainty surrounding the potential causal links between COVID-19-related factors and digestive diseases. Our findings suggest that genetic variants associated with COVID-19 infection and vaccination do not significantly influence the risk of these diseases, which could inform clinical treatment strategies and public health guidelines.
Keywords: COVID−19; Digestive diseases; Mendelian randomization.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable, since the study is based on summary-level data. In all original studies, ethical approval and consent to participate had been obtained. Competing interests: The authors declare no competing interests.
Figures









Similar articles
-
Causal association of polyunsaturated fatty acids with biliary tract diseases: A Mendelian randomization study.Clin Nutr ESPEN. 2024 Jun;61:37-45. doi: 10.1016/j.clnesp.2024.03.009. Epub 2024 Mar 12. Clin Nutr ESPEN. 2024. PMID: 38777457
-
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780. Cochrane Database Syst Rev. 2024. PMID: 39679851 Free PMC article.
-
Antibody tests for identification of current and past infection with SARS-CoV-2.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article.
-
Exploring causal relationships between brain imaging-derived phenotypes and ovarian cancer risk: a bidirectional Mendelian randomization.J Ovarian Res. 2025 Aug 1;18(1):173. doi: 10.1186/s13048-025-01733-z. J Ovarian Res. 2025. PMID: 40751201 Free PMC article.
-
Physical interventions to interrupt or reduce the spread of respiratory viruses.Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6. Cochrane Database Syst Rev. 2023. PMID: 36715243 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical